La Mesa, CA – September 8, 2023 – Two industry titans, Gold Colloid, Co., a trailblazing point-of-care (POC) test development company, and Claremont BioSolutions LLC, an innovator in life science tools, have just unveiled a groundbreaking distribution agreement for Gold Colloid’s prized gold nanoparticles.
This partnership heralds a new era, as Claremont BioSolutions gains exclusive rights to distribute Gold Colloid’s gold nanoparticles across the life sciences, medical, and environmental testing sectors. These miraculous nanoparticles find application in diagnostics, biosensing, and bioimaging, promising to revolutionize the way we approach healthcare and environmental analysis.
Daniel Levenson, the visionary President of Gold Colloid, exclaimed, “We are thrilled to join forces with Claremont BioSolutions to unleash the potential of our gold nanoparticles. Claremont BioSolutions boasts an illustrious track record in the life sciences arena, and we firmly believe that this collaboration will empower us to reach an even broader and more diverse clientele.”
Dr. Robert Doebler, the esteemed President of Claremont BioSolutions, echoed the sentiment, stating, “Our partnership with Gold Colloid to distribute their gold nanoparticles marks an exciting milestone. For over 5 years, we have entrusted Gold Colloid Company’s exceptional 40nm gold nanoparticles in our operations. This collaboration is poised to cater to the evolving demands of our numerous R&D customers who value the exceptional quality of highly monodisperse gold nanoparticles, especially in lateral flow assay development.” The future of science has just become brighter!